Skip to main content

It’s triple-check for science reporting (hindu)

Medical stories should be complete and carefully verified

Since the office of the Readers’ Editor was established in The Hindu in 2006, one reader has been relentless in his pursuit for accuracy. He has an excellent eye for detail and a phenomenal memory of sporting events. Dr. Maniyur Raghavendran is a consultant urologist and transplant surgeon. While most of his letters are about slip ups in sports stories, his recent mail questioned the credibility of a journal cited in a medical story.

The report, “Woman takes risk, achieves motherhood after 20 miscarriages” (April 15, 2017), was filed by the Nellore staff reporter. It was a moving story about a woman who wanted to have a child despite difficult medical conditions, and who was ready to take a risk because her husband’s family was pressuring him to marry again. The report was based on interviews with the woman and her doctor. It was a good human-interest story, but was marred by the strapline which read: “In view of the rare nature, her medical report entered the International Journal of Reproduction, says expert.”

Dr. Raghavendran wrote: “I tried searching for this journal, but this seems to be an open access journal where you pay and get your report published. Does The Hindu need to highlight such cases entered in fictitious journals?”

Guidelines for science reporting
I agree with Dr. Raghavendran. It is important for staff reporters and regional desks to read the 2012 internal circular that spelt out the rules for reporting on science and health. The operative part of that circular is this: “Medical stories should be complete and carefully verified; cutting corners for whatever reason, including competitive pressures, is impermissible. Please run such stories by the Science Editor or senior health writers before pitching them to the editorial desk. Do not mail these stories to the Net. If you are not a designated health reporter in a bureau, all stories on press releases on medical claims must be routed through one of our senior editorial experts and not filed directly by general reporters. If such a process takes time, so be it: a story could be held over to check the claims made.”

In my column, “Tall claim is not science” (January 18, 2016), I shared some of the best practices in science and health reporting. The article dealt with the quality of academic journals, and what a reporter can rely upon. Those guidelines are: “Check the quality of peer review, as different journals have different criteria and practices, and the quality of their peer review varies accordingly. Try to find out the limitations of the study: was it too preliminary or too small a sample size to be accepted in a higher quality journal? Be critical if the claim is made in a public statement. How credible is the scientist among his/her scientific peers? Is the scientist based at a recognised scientific institution? How is the study funded? Finding an independent expert to comment is the most reliable way to judge the validity of a study.”

Predatory journals in India
R. Prasad, Science Editor of The Hindu, in “Predatory journals make desperate bid for authenticity” (April 20, 2017), explained how India has a huge and growing number of predatory journal publishers. He looked at data from the India office of the Directory of Open Access Journals (DOAJ) since March 2014, when the new criteria for DOAJ listings were put out. Mr. Prasad wrote that out of 1,600 applications from open access journal publishers in India, only 4% were found to be from genuine publishers and accepted for inclusion in the DOAJ directory. While 18% of the applications are still being processed, Mr. Prasad contends that the main reason for the rejection of 78% of the applications is the predatory or dubious nature of the journals.

There are some fine journalistic clues in Mr. Prasad’s article. For instance, he cites Bengaluru-based Leena Shah, DOAJ ambassador, India, who gives two important entry points to assess the journal: “Nearly 20% of the journals have a flashy impact factor and quick publication time, which are quick give-aways… Under contact address, some journal websites do not provide any address but just a provision for comments.”

While reporting human-interest stories that have a substantial scientific component to it, general reporters should imbibe the rules and norms of science reporting. While double-check is the norm for general reporting, it is triple-check for science reporting.

Popular posts from this blog

NGT terminates chairmen of pollution control boards in 10 states (downtoearth,)

Cracking the whip on 10 State Pollution Control Boards (SPCBs) for ad-hoc appointments, the National Green Tribunal has ordered the termination of Chairpersons of these regulatory authorities. The concerned states are Himachal Pradesh, Sikkim, Tamil Nadu, Uttarakhand, Kerala, Rajasthan, Telangana, Haryana, Maharashtra and Manipur. The order was given last week by the principal bench of the NGT, chaired by Justice Swatanter Kumar. The recent order of June 8, 2017, comes as a follow-up to an NGT judgment given in August 2016. In that judgment, the NGT had issued directions on appointments of Chairmen and Member Secretaries of the SPCBs, emphasising on crucial roles they have in pollution control and abatement. It then specified required qualifications as well as tenure of the authorities. States were required to act on the orders within three months and frame Rules for appointment [See Box: Highlights of the NGT judgment of 2016 on criteria for SPCB chairperson appointment]. Having

High dose of Vitamin C and B3 can kill colon cancer cells: study (downtoearth)

In a first, a team of researchers has found that high doses of Vitamin C and niacin or Vitamin B3 can kill cancer stem cells. A study published in Cell Biology International showed the opposing effects of low and high dose of vitamin C and vitamin B3 on colon cancer stem cells. Led by Bipasha Bose and Sudheer Shenoy, the team found that while low doses (5-25 micromolar) of Vitamin C and B3 proliferate colon cancer stem cells, high doses (100 to 1,000 micromolar) killed cancer stem cells. Such high doses of vitamins can only be achieved through intravenous injections in colon cancer patients. The third leading cause of cancer deaths worldwide, colon cancer can be prevented by an intake of dietary fibre and lifestyle changes. While the next step of the researchers is to delineate the mechanisms involved in such opposing effects, they also hope to establish a therapeutic dose of Vitamin C and B3 for colon cancer stem cell therapy. “If the therapeutic dose gets validated under in vivo

SC asks Centre to strike a balance on Rohingya issue (.hindu)

Supreme Court orally indicates that the government should not deport Rohingya “now” as the Centre prevails over it to not record any such views in its formal order, citing “international ramifications”. The Supreme Court on Friday came close to ordering the government not to deport the Rohingya. It finally settled on merely observing that a balance should be struck between humanitarian concern for the community and the country's national security and economic interests. The court was hearing a bunch of petitions, one filed by persons within the Rohingya community, against a proposed move to deport over 40,000 Rohingya refugees. A three-judge Bench, led by Chief Justice of India Dipak Misra, began by orally indicating that the government should not deport Rohingya “now”, but the government prevailed on the court to not pass any formal order, citing “international ramifications”. With this, the status quo continues even though the court gave the community liberty to approach i